Please login to the form below

Not currently logged in
Email:
Password:

neuroscience

This page shows the latest neuroscience news and features for those working in and with pharma, biotech and healthcare.

Bristol Myers Squibb announces data on Zeposia from DAYBREAK study in MS

Bristol Myers Squibb announces data on Zeposia from DAYBREAK study in MS

Clinical Neurology, University of California San Francisco (UCSF) Weill Institute for Neurosciences and clinical research director, UCSF MS Center.

Latest news

More from news
Approximately 13 fully matching, plus 187 partially matching documents found.

Latest Intelligence

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    And that’s definitely good news for all of us. Peter Schueler is a Neurologist and Sr VP Drug Development Neurosciences at ICON plc.

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    MindMaze, the Swiss start-up which entered the unicorn club in 2016, works at the intersection of neuroscience, mixed reality and artificial intelligence and builds intuitive human machine interfaces for different

  • The search for treatments for Parkinson’s disease The search for treatments for Parkinson’s disease

    The reactions to Pfizer dropping neuroscience research ranged from ‘disappointing’ to ‘demoralising’.The move was compounded by the company saying the decision was driven by science rather than cost, a shockwave ... It’s snakes and ladders.

  • AI and genomics: a revolution in drug discovery and development AI and genomics: a revolution in drug discovery and development

    Ten of the new ALS-related genes are being tested using an existing neural progenitor cell assay at the Sheffield Institute for Translational Neuroscience (SITraN).

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    In 2018, venture capitalists invested almost $1.5bn (1.4bn) in neuroscience biotechs, an increase of more than 500% over funding levels in 2011. ... Dave Reese, head of R&D at Amgen, touched on those issues to explain Amgen’s exit from neuroscience

More from intelligence
Approximately 2 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 44 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 23 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....